ClinicalTrials.gg
CompletedNCT07288047CALM-VRUpdated Nov 20, 2026

Virtual Reality as a Method for Pain and Anxiety Control During First Trimester Procedural Abortion

An interventional study of VR headset and Usual Care in Abortion, First Trimester, Pain Management and Pain After Surgery, sponsored by Study Investigator. Completed at 2 sites in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-20.

Sponsored by Study Investigator · Not applicable, Interventional, and Supportive care

How we know

Updated Nov 20, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
71
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 91 studies in Personal Satisfaction with a site in United States — 6 open to participants now, 8 under way, none of them phase 3. Personal Satisfaction · United States.

Enrollment
55th of 80
71 · median 117
Started
2026
with 3 others
No phase
65 of 91
4 open now
Registered
89th of 91
by date

Among the 91 studies in Personal Satisfaction with a site in United States, this one is the 55th largest by enrollment of the 80 interventional ones that give a count, is one of 4 that started in 2026, is one of 65 with no phase, and was the 89th registered.

Personal Satisfaction

543 studies on the registry are indexed under Personal Satisfaction; 91 are open to participants now.

Browse Personal Satisfaction studies →

Open to participants now

6 of the 91 studies in Personal Satisfaction with a site in United States are open now. Recruiting first, the newest first:

1 more — sign in →

All 6 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 38 Personal Satisfaction studies recruiting now, 18 (47%) set no upper age limit and 15 (39%) stop at 75 or younger; 8 take children under 18; 20 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 91 studies in Personal Satisfaction with a site in United States, or all of them as a file.
02

Study summary

The goal of this clinical trial is to learn whether use of a virtual reality (VR) headset showing a meditative nature video will help reduce pain and anxiety during a first trimester procedural abortion. Investigators will enroll 72 patients undergoing a first trimester procedural abortion with usual care to manage pain and anxiety compared to use of a VR headset in addition to usual care to see if use of the VR headset will decrease pain and anxiety and increase satisfaction with the procedure.

Read the detailed description

While procedural abortions are common outpatient procedures, providing optimal pain and anxiety relief during these procedures is challenging. With rapidly developing technological advances, virtual reality (VR) has emerged as a promising modality to help manage pain and anxiety control in the medical field, including obstetrics and gynecology. However, there are no studies evaluating the effect of VR on pain during a procedural abortion.

The goal of this randomized controlled trial is to primarily evaluate whether using a VR headset to display a meditative nature video as a noninvasive, low risk technology may reduce pain and anxiety for patients undergoing a first trimester procedural abortion in an outpatient setting. Investigators will also evaluate factors influencing satisfaction with the procedure. Investigators will compare use of the VR headset with usual care, to usual care only; for a first trimester procedural abortion, usual care includes oral pain medications, local anesthetic medication in the cervix, and verbal reassurance. Participants will be asked to complete a survey before, after, and one week following the procedure to assess pain, anxiety, and overall satisfaction.

03

Conditions studied

  • Abortion, First Trimester
  • Pain Management
  • Pain After Surgery
  • Satisfaction
  • Satisfaction With Care
  • Anxiety After Surgery

Browse trials for

Keywords

  • satisfaction
  • virtual reality
  • procedural abortion
  • pain control
  • anxiety control
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients at Planned Parenthood of Western Pennsylvania who have decided to undergo and are eligible for a procedural abortion.
  • 18 years old or older
  • \<14 weeks gestation on day of abortion
  • Able to comprehend written English
  • Willing to comply with the study protocol
  • Willing and able to provide

Exclusion criteria

Exclusion Criteria:

  • History of vertigo
  • History of epilepsy
  • Claustrophobia
  • Significant hearing or visual impairments (such as deafness or blindness)
  • Require hearing aids
  • Have an implanted medical device, such as cardiac pacemaker or defibrillator
  • Require misoprostol for cervical preparation
  • Prior unsuccessful attempt at abortion during this pregnancy
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
71 participants (actual)

Study arms

  • Active comparator
    Usual care only

    Usual care for pain and anxiety management during a first trimester procedural abortion includes oral ibuprofen, intracervical block, and verbal analgesia.

    Other: Usual Care

  • Experimental
    VR headset

    Participants will wear the VR headset during the first trimester procedural abortion, in addition to usual care for pain and anxiety management. The headset will display a meditative nature video throughout the procedure.

    Device: VR headset · Other: Usual Care

Interventions

  • DeviceVR headset

    VR Headset: Meta Quest 3S Meditative nature videos provided via "Guided Meditation VR" app.

  • OtherUsual Care

    Usual care for pain and anxiety management during a first trimester procedural abortion includes oral ibuprofen, intracervical block, and verbal analgesia.

    Also known as: Routine care

06

What researchers measure

Primary outcomes

  1. Pain scores during a first trimester procedural abortion

    Pain will be measured on a visual analogue scale during and after the procedural abortion via a REDCap survey. The scale is from 0-100, with 0 being "No pain" and 100 being the "Worst pain of my life". The difference in this score (post-procedure minus pre-procedure) is what will be compared between study arms.

    Time frame: Day of enrollment: immediately preprocedure and 15 minutes postprocedure.

  2. Anxiety scores during a first trimester procedural abortion

    Anxiety will be measured on a visual analogue scale during and after the procedural abortion via a REDCap survey. The scale is from 0-100, with 0 being "No anxiety or fear" and 100 being the "Worst anxiety or fear of my life". The difference in this score (post-procedure minus pre-procedure) is what will be compared between study arms.

    Time frame: Day of enrollment: immediately preprocedure and 15 minutes postprocedure.

Secondary outcomes

  1. Satisfaction with the first trimester procedural abortion

    Satisfaction will be assessed on a Likert scale using surveys administered on the day of the procedure and one week after the procedure. A score of 1 = very dissatisfied, and a score of 5 = very satisfied.

    Time frame: Day of enrollment (immediately postprocedure) and one week after completion of the procedural abortion.

07

Study locations

2 sites
  • Center for Family Planning Research, Magee-Womens Hospital
    Pittsburgh, Pennsylvania 15213, United States
  • Planned Parenthood of Western Pennsylvania
    Pittsburgh, Pennsylvania 15213, United States
08

References and documents

Individual participant data

Plan to share: No — There are currently no plans to share the data, however it is possible we may choose to share the data with other groups or individuals interested in this topic. Should we choose to share, the data will be de-identified and a data use agreement will be executed as needed.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2026 to primary completion in Aug 2026, 3 months.

Of 250 non-industry interventional studies with no phase under Personal Satisfaction, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 21. This study's 3 months is below that.

Counting every sponsor, half of 257 studies reached it within 9 months; a quarter within 3 and three quarters within 21.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 20, 2026: primary completion Oct 2026 → Aug 2026 and completion Oct 2026 → Aug 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Dec 11, 2025
First posted
Dec 17, 2025
StartActual
May 1, 2026
Primary completionActual
Aug 15, 2026was Oct 2026
CompletionActual
Aug 22, 2026was Oct 2026
Last update
Nov 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Nov 20, 2026
Primary completion
Oct 30, 2026→Aug 15, 2026 (actual)
Nov 20, 2026
Study completion
Oct 30, 2026→Aug 22, 2026 (actual)
Nov 20, 2026
Enrollment
72 (estimated)→71 (actual)
Nov 20, 2026
Show all 1 update
  1. Nov 20, 2026
    Recruiting→Completed
    Primary completion Oct 30, 2026→Aug 15, 2026 (now actual)
    Study completion Oct 30, 2026→Aug 22, 2026 (now actual)
    Enrollment 72 (estimated)→71 (actual)
    + 3 other changes: verification date, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07288047
Lead sponsor
Study Investigator
Responsible party
Study Investigator (Fellow, University of Pittsburgh) — Sponsor-investigator
First posted
Dec 17, 2025
Start date
May 1, 2026
Primary completion
Aug 15, 2026
Completion
Aug 22, 2026
Last update
Nov 20, 2026

Study contacts

Study Coordinator
study director · Univeristy of Pittsburgh

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion